Form of pyrimidine compound having dibenzylamine structure

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9682942
SERIAL NO

14784147

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

It is an object of the present invention to provide a novel form of (S)-trans-{4-[({2-[({1-[3,5-bis(trifluoromethyl)phenyl]ethyl}{5-[2-(methylsulfonyl)ethoxy]pyrimidin-2-yl}amino)methyl]-4-(trifluoromethyl)phenyl}(ethyl)amino)methyl]cyclohexyl}acetic acid, which is useful for preventing and/or treating diseases such as dyslipidemia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KOWA COMPANY LTDNAGOYA-SHI AICHI 460-8625

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kusakabe, Taichi Chiba, JP 6 7
Matsuda, Kennosuke Tokyo, JP 3 2
Ohgiya, Tadaaki Saitama, JP 56 154
Shibuya, Kimiyuki Saitama, JP 57 114
Yamazaki, Koichi Tokyo, JP 75 727

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 20, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 20, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00